Detail
| LncRNA Name | LOC441242 |
| Synonyms | RP11-479O9.4, LOC441242 |
| Region | NA Sequence |
| Ensembl | NA |
| RefSeq | NA |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✘ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | triple negative breast cancer |
| ICD-0-3 | C50 |
| Methods | microarray, qPCR etc. |
| Sample | primary breast cancer tissues, cell lines (MDA-MB-231, HCC-1937, MDA-MB-468, MDA-MB-453 etc.) |
| Expression Pattern | down-regulated |
| Function Description | The qRT-PCR results showed that, compared with non-TNBC tissues, C17orf76-AS1 and CTC-338M12.3 were dominantly up-regulated in TNBC tissues; on the other hand, RP11-434D9.1, IGKV, LINC00052, BC016831, RP4-781K5.4, and LOC441242 were obviously down-regulated. |
| Pubmed ID | 26910840 |
| Year | 2016 |
| Title | LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer. |
| External Links |
| Links for LOC441242 | GenBank HGNC lncrnadb Noncode |
| Links for triple negative breast cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.